Amedisys Reports Second Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Amedisys (AMED) Tops Q2 EPS by 10c
July 29, 2015 7:41 AM EDTAmedisys (NASDAQ: AMED) reported Q2 EPS of $0.43, $0.10 better than the analyst estimate of $0.33. Revenue for the quarter came in at $314.2 million versus the consensus estimate of $307.11 million.
For earnings history and earnings-related data on Amedisys (AMED) click here.
... More